Efficacy of a topical sesame/rose geranium oil compound in patients with hereditary hemorrhagic telangiectasia associated epistaxis

Douglas D. Reh, Kevin Hur, Christian Merlo

Research output: Contribution to journalArticle

Abstract

Objectives/Hypothesis: Topical Sesame/Rose geranium oil compound is an effective therapy for hereditary hemorrhagic telangiectasia (HHT) associated epistaxis. Study Design: Cohort Study. Methods: Twenty patients with HHT confirmed by the Curaçao criteria were treated with a sesame/rose geranium oil topical compound between January 2010 and June 2011. A treatment evaluation survey was conducted at least 3 months after treatment initiation. Changes in epistaxis severity scores (ESS), patient satisfaction, and any adverse effects were assessed. Results: A total of 20 patients completed the study. The average (SD) age was 54.4 (14.6), and 14 (70%) were female. The median time on rose geranium oil was 183 days (IQR: 114-311). At the conclusion of the study, 18 (90%) were still using rose geranium oil. The majority (75%) of patients subjectively felt improvement with the treatment. The improvement was felt to be gradual in 25% and immediate in 50% of patients. Mean (SD) overall satisfaction using a 10-point Likert scale was 7.8 (3.1), with 50% of the patients reporting a satisfaction rating of 10. Mean (SD) epistaxis severity score (ESS) prior to treatment was 5.3 (1.7). After treatment with sesame/rose geranium oil, mean (SD) ESS was found to be 3.5 (1.8). Treatment with sesame/rose geranium oil was associated with a statistically significant improvement in ESS by 1.81 (P

Original languageEnglish (US)
Pages (from-to)820-822
Number of pages3
JournalLaryngoscope
Volume123
Issue number4
DOIs
StatePublished - Apr 2013

Fingerprint

Geranium
Sesamum
Hereditary Hemorrhagic Telangiectasia
Epistaxis
Oils
Therapeutics
Patient Satisfaction
Cohort Studies

Keywords

  • epistaxis
  • Hereditary hemorrhagic telangiectasia
  • Osler-Weber
  • rose geranium oil
  • sesame oil
  • treatment

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Efficacy of a topical sesame/rose geranium oil compound in patients with hereditary hemorrhagic telangiectasia associated epistaxis. / Reh, Douglas D.; Hur, Kevin; Merlo, Christian.

In: Laryngoscope, Vol. 123, No. 4, 04.2013, p. 820-822.

Research output: Contribution to journalArticle

@article{cefb46d9aec348e0be7600eb34eac0d4,
title = "Efficacy of a topical sesame/rose geranium oil compound in patients with hereditary hemorrhagic telangiectasia associated epistaxis",
abstract = "Objectives/Hypothesis: Topical Sesame/Rose geranium oil compound is an effective therapy for hereditary hemorrhagic telangiectasia (HHT) associated epistaxis. Study Design: Cohort Study. Methods: Twenty patients with HHT confirmed by the Cura{\cc}ao criteria were treated with a sesame/rose geranium oil topical compound between January 2010 and June 2011. A treatment evaluation survey was conducted at least 3 months after treatment initiation. Changes in epistaxis severity scores (ESS), patient satisfaction, and any adverse effects were assessed. Results: A total of 20 patients completed the study. The average (SD) age was 54.4 (14.6), and 14 (70{\%}) were female. The median time on rose geranium oil was 183 days (IQR: 114-311). At the conclusion of the study, 18 (90{\%}) were still using rose geranium oil. The majority (75{\%}) of patients subjectively felt improvement with the treatment. The improvement was felt to be gradual in 25{\%} and immediate in 50{\%} of patients. Mean (SD) overall satisfaction using a 10-point Likert scale was 7.8 (3.1), with 50{\%} of the patients reporting a satisfaction rating of 10. Mean (SD) epistaxis severity score (ESS) prior to treatment was 5.3 (1.7). After treatment with sesame/rose geranium oil, mean (SD) ESS was found to be 3.5 (1.8). Treatment with sesame/rose geranium oil was associated with a statistically significant improvement in ESS by 1.81 (P",
keywords = "epistaxis, Hereditary hemorrhagic telangiectasia, Osler-Weber, rose geranium oil, sesame oil, treatment",
author = "Reh, {Douglas D.} and Kevin Hur and Christian Merlo",
year = "2013",
month = "4",
doi = "10.1002/lary.23736",
language = "English (US)",
volume = "123",
pages = "820--822",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Efficacy of a topical sesame/rose geranium oil compound in patients with hereditary hemorrhagic telangiectasia associated epistaxis

AU - Reh, Douglas D.

AU - Hur, Kevin

AU - Merlo, Christian

PY - 2013/4

Y1 - 2013/4

N2 - Objectives/Hypothesis: Topical Sesame/Rose geranium oil compound is an effective therapy for hereditary hemorrhagic telangiectasia (HHT) associated epistaxis. Study Design: Cohort Study. Methods: Twenty patients with HHT confirmed by the Curaçao criteria were treated with a sesame/rose geranium oil topical compound between January 2010 and June 2011. A treatment evaluation survey was conducted at least 3 months after treatment initiation. Changes in epistaxis severity scores (ESS), patient satisfaction, and any adverse effects were assessed. Results: A total of 20 patients completed the study. The average (SD) age was 54.4 (14.6), and 14 (70%) were female. The median time on rose geranium oil was 183 days (IQR: 114-311). At the conclusion of the study, 18 (90%) were still using rose geranium oil. The majority (75%) of patients subjectively felt improvement with the treatment. The improvement was felt to be gradual in 25% and immediate in 50% of patients. Mean (SD) overall satisfaction using a 10-point Likert scale was 7.8 (3.1), with 50% of the patients reporting a satisfaction rating of 10. Mean (SD) epistaxis severity score (ESS) prior to treatment was 5.3 (1.7). After treatment with sesame/rose geranium oil, mean (SD) ESS was found to be 3.5 (1.8). Treatment with sesame/rose geranium oil was associated with a statistically significant improvement in ESS by 1.81 (P

AB - Objectives/Hypothesis: Topical Sesame/Rose geranium oil compound is an effective therapy for hereditary hemorrhagic telangiectasia (HHT) associated epistaxis. Study Design: Cohort Study. Methods: Twenty patients with HHT confirmed by the Curaçao criteria were treated with a sesame/rose geranium oil topical compound between January 2010 and June 2011. A treatment evaluation survey was conducted at least 3 months after treatment initiation. Changes in epistaxis severity scores (ESS), patient satisfaction, and any adverse effects were assessed. Results: A total of 20 patients completed the study. The average (SD) age was 54.4 (14.6), and 14 (70%) were female. The median time on rose geranium oil was 183 days (IQR: 114-311). At the conclusion of the study, 18 (90%) were still using rose geranium oil. The majority (75%) of patients subjectively felt improvement with the treatment. The improvement was felt to be gradual in 25% and immediate in 50% of patients. Mean (SD) overall satisfaction using a 10-point Likert scale was 7.8 (3.1), with 50% of the patients reporting a satisfaction rating of 10. Mean (SD) epistaxis severity score (ESS) prior to treatment was 5.3 (1.7). After treatment with sesame/rose geranium oil, mean (SD) ESS was found to be 3.5 (1.8). Treatment with sesame/rose geranium oil was associated with a statistically significant improvement in ESS by 1.81 (P

KW - epistaxis

KW - Hereditary hemorrhagic telangiectasia

KW - Osler-Weber

KW - rose geranium oil

KW - sesame oil

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=84875414444&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875414444&partnerID=8YFLogxK

U2 - 10.1002/lary.23736

DO - 10.1002/lary.23736

M3 - Article

C2 - 23401038

AN - SCOPUS:84875414444

VL - 123

SP - 820

EP - 822

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 4

ER -